PCHM Stock Overview
PharmChem, Inc. proporciona PharmChek Sweat Patch que se utiliza para detectar drogas de abuso.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PharmChem, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.76 |
| 52 Week High | US$3.57 |
| 52 Week Low | US$2.10 |
| Beta | 0 |
| 1 Month Change | 5.34% |
| 3 Month Change | 9.52% |
| 1 Year Change | 1.38% |
| 3 Year Change | -46.92% |
| 5 Year Change | 245.00% |
| Change since IPO | -70.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCHM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.8% | -3.4% | -2.1% |
| 1Y | 1.4% | 6.4% | 24.7% |
Rentabilidad frente al sector: PCHM obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del 11.3%.
Rentabilidad vs. Mercado: PCHM obtuvo unos resultados inferiores a los del mercado US, que fue del 22.3% el año pasado.
Price Volatility
| PCHM volatility | |
|---|---|
| PCHM Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: PCHMha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de PCHM en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Thompson Clark | https://www.pharmchek.com |
PharmChem, Inc. proporciona PharmChek Sweat Patch que se utiliza para detectar drogas de abuso. Su PharmChek Sweat Patch utiliza el sudor como fuente y ofrece una alternativa a los análisis de orina para detectar cocaína, opiáceos, anfetaminas, PCP y marihuana. La empresa se constituyó en 2000 y tiene su sede en Fort Worth, Texas.
PharmChem, Inc. Fundamentals Summary
| PCHM fundamental statistics | |
|---|---|
| Market cap | US$12.36m |
| Earnings (TTM) | -US$2.04m |
| Revenue (TTM) | US$25.73m |
0.0x
P/S Ratio0.0x
P/E RatioIs PCHM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCHM income statement (TTM) | |
|---|---|
| Revenue | US$25.73m |
| Cost of Revenue | US$19.98m |
| Gross Profit | US$5.74m |
| Other Expenses | US$7.78m |
| Earnings | -US$2.04m |
Last Reported Earnings
Mar 31, 2004
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PCHM perform over the long term?
See historical performance and comparison